Works matching DE "ANTINEOPLASTIC agents"
Results: 5000
Peut-on parler d'un traitement curatif par évérolimus d'un phénomène de Kasabach-Merritt compliquant un angiome en touffes ?
- Published in:
- 2025
- By:
- Publication type:
- Case Study
A novel trifluoromethyl quinoline derivative targeting SGK1 inducing autophagy and apoptosis via regulating mTOR/FOXO3a pathway in glioblastoma.
- Published in:
- Arabian Journal of Chemistry, 2024, v. 17, n. 9, p. N.PAG, doi. 10.1016/j.arabjc.2024.105909
- By:
- Publication type:
- Article
Computer‐Aided Design of VEGFR‐2 Inhibitors as Anticancer Agents: A Review.
- Published in:
- Journal of Molecular Recognition, 2025, v. 38, n. 1, p. 1, doi. 10.1002/jmr.3104
- By:
- Publication type:
- Article
Trametinib Suppresses the Stimulated T Cells Through G1 Arrest and Apoptosis.
- Published in:
- European Journal of Immunology, 2025, v. 55, n. 2, p. 1, doi. 10.1002/eji.202350667
- By:
- Publication type:
- Article
Tumor‐Expressed SPPL3 Supports Innate Antitumor Immune Responses.
- Published in:
- European Journal of Immunology, 2025, v. 55, n. 2, p. 1, doi. 10.1002/eji.202451129
- By:
- Publication type:
- Article
Function and Spatial Organization of Tumor‐Invasive Human γδ T Cells—What Do We Know?
- Published in:
- European Journal of Immunology, 2025, v. 55, n. 1, p. 1, doi. 10.1002/eji.202451075
- By:
- Publication type:
- Article
Repurposing bosentan as an anticancer agent: EGFR/ERK/c‐Jun modulation inhibits NSCLC tumor growth.
- Published in:
- Fundamental & Clinical Pharmacology, 2025, v. 39, n. 1, p. 1, doi. 10.1111/fcp.13052
- By:
- Publication type:
- Article
Capivasertib augments chemotherapy via Akt inhibition in preclinical small cell lung cancer models.
- Published in:
- Fundamental & Clinical Pharmacology, 2025, v. 39, n. 1, p. 1, doi. 10.1111/fcp.13042
- By:
- Publication type:
- Article
Multicomponent Polymerization toward Poly(BODIPY‐sulfonamide)s as Unique SO<sub>2</sub> Generators for Sonodynamic and Gas Combination Therapy.
- Published in:
- Angewandte Chemie, 2025, v. 137, n. 13, p. 1, doi. 10.1002/ange.202422362
- By:
- Publication type:
- Article
Patidegib: a novel, promising treatment for basal cell carcinoma lesions in patients with Gorlin syndrome.
- Published in:
- British Journal of Dermatology, 2025, v. 192, n. 4, p. 565, doi. 10.1093/bjd/ljae515
- By:
- Publication type:
- Article
Carcinoid syndrome presenting as diffuse violaceous cutaneous flushing.
- Published in:
- British Journal of Dermatology, 2025, v. 192, n. 4, p. 772, doi. 10.1093/bjd/ljae424
- By:
- Publication type:
- Article
Preclinical studies on the antitumor and non‐toxic effect of combining pirfenidone with vinorelbine and carboplatin in non‐small cell lung cancer.
- Published in:
- International Journal of Cancer, 2025, v. 156, n. 9, p. 1756, doi. 10.1002/ijc.35276
- By:
- Publication type:
- Article
EXPRESSION OF CONCERN: Antitumor Effects of a Novel Sulfur‐Containing Hydroxamate Histone Deacetylase Inhibitor H40.
- Published in:
- International Journal of Cancer, 2025, v. 156, n. 9, p. E14, doi. 10.1002/ijc.35373
- Publication type:
- Article
Effects of MCL‐1 expression in colorectal cancer.
- Published in:
- International Journal of Cancer, 2025, v. 156, n. 8, p. 1499, doi. 10.1002/ijc.35308
- By:
- Publication type:
- Article
Clinical outcomes by baseline metastases in patients with renal cell carcinoma treated with lenvatinib plus pembrolizumab versus sunitinib: Post hoc analysis of the CLEAR trial.
- Published in:
- International Journal of Cancer, 2025, v. 156, n. 7, p. 1326, doi. 10.1002/ijc.35288
- By:
- Publication type:
- Article
Unleashing viral mimicry: A combinatorial strategy to enhance the efficacy of PARP7 inhibitors.
- Published in:
- BioEssays, 2025, v. 47, n. 2, p. 1, doi. 10.1002/bies.202400087
- By:
- Publication type:
- Article
Value-Based Indication-Specific Pricing and Weighted-Average Pricing: Estimated Price and Cost Savings for Cancer Drugs: Indication-Specific Pricing and Weighted-Average Pricing: D. T. Michaeli, T. Michaeli.
- Published in:
- PharmacoEconomics, 2025, v. 43, n. 4, p. 415, doi. 10.1007/s40273-024-01448-x
- By:
- Publication type:
- Article
Single‐Step Isolation of Phyllacanthone From Cnidoscolus quercifolius Using Centrifugal Partition Chromatography.
- Published in:
- Journal of Separation Science, 2025, v. 48, n. 2, p. 1, doi. 10.1002/jssc.70094
- By:
- Publication type:
- Article
Study on Interaction Between 5‐(4 Methoxyphenyl)‐1‐Phenyl‐1H‐1,2,3‐Triazole with High‐Abundant Blood Proteins and Identification of Low‐Abundant Proteins by Serum Proteomics.
- Published in:
- Journal of Separation Science, 2025, v. 48, n. 1, p. 1, doi. 10.1002/jssc.70083
- By:
- Publication type:
- Article
"Angular" Spirocyclic Azetidines: Synthesis, Characterization, and Evaluation in Drug Discovery.
- Published in:
- Angewandte Chemie, 2025, v. 137, n. 7, p. 1, doi. 10.1002/ange.202418850
- By:
- Publication type:
- Article
GD2-targeted theranostics of neuroblastoma with [<sup>64</sup>Cu]Cu/[<sup>177</sup>Lu]Lu-hu3F8.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 5, p. 1764, doi. 10.1007/s00259-024-07033-w
- By:
- Publication type:
- Article
Editorial Comment to "Management of apalutamide‐induced rash with focus on early peaks".
- Published in:
- International Journal of Urology, 2025, v. 32, n. 1, p. 117, doi. 10.1111/iju.15611
- By:
- Publication type:
- Article
Editorial Comment on "Management of apalutamide‐induced rash with focus on early peaks".
- Published in:
- International Journal of Urology, 2025, v. 32, n. 1, p. 116, doi. 10.1111/iju.15606
- By:
- Publication type:
- Article
Management of apalutamide‐induced rash with focus on early peaks.
- Published in:
- International Journal of Urology, 2025, v. 32, n. 1, p. 113, doi. 10.1111/iju.15587
- By:
- Publication type:
- Article
Parents' experiences on handling paediatric anticancer drugs at home after an educational intervention.
- Published in:
- Journal of Evaluation in Clinical Practice, 2025, v. 31, n. 1, p. 1, doi. 10.1111/jep.14089
- By:
- Publication type:
- Article
In silico docking analysis of bioactive compounds from Adansonia digitata L. against protein tyrosine phosphate.
- Published in:
- AYU: An International Quarterly Journal of Research in Ayurveda, 2024, v. 45, n. 3, p. 153, doi. 10.4103/ayu.ayu_322_21
- By:
- Publication type:
- Article
Revisiting the association between sodium-glucose cotransporter-2 inhibitors and the risk of neoplasm in patients with type 2 diabetes: new insights from an updated systematic review and meta-analysis of randomized controlled trials.
- Published in:
- Expert Review of Clinical Pharmacology, 2025, v. 18, n. 3, p. 165, doi. 10.1080/17512433.2024.2439970
- By:
- Publication type:
- Article
Improvement of assessment in surrogate endpoint and safety outcome of single-arm trials for anticancer drugs.
- Published in:
- Expert Review of Clinical Pharmacology, 2024, v. 17, n. 5/6, p. 477, doi. 10.1080/17512433.2024.2344669
- By:
- Publication type:
- Article
A pan‐tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors.
- Published in:
- CA: A Cancer Journal for Clinicians, 2025, v. 75, n. 2, p. 141, doi. 10.3322/caac.21870
- By:
- Publication type:
- Article
The application of snake venom in anticancer drug discovery: an overview of the latest developments.
- Published in:
- Expert Opinion on Drug Discovery, 2025, v. 20, n. 3, p. 317, doi. 10.1080/17460441.2025.2465364
- By:
- Publication type:
- Article
Omega-3 polyunsaturated fatty acid derived lipid mediators: a comprehensive update on their application in anti-cancer drug discovery.
- Published in:
- Expert Opinion on Drug Discovery, 2024, v. 19, n. 5, p. 617, doi. 10.1080/17460441.2024.2340493
- By:
- Publication type:
- Article
Relacorilant in recurrent ovarian cancer: clinical evidence and future perspectives.
- Published in:
- Expert Review of Anticancer Therapy, 2024, v. 24, n. 8, p. 649, doi. 10.1080/14737140.2024.2362178
- By:
- Publication type:
- Article
Are statins onco- suppressive agents for every type of tumor? A systematic review of literature.
- Published in:
- Expert Review of Anticancer Therapy, 2024, v. 24, n. 6, p. 435, doi. 10.1080/14737140.2024.2343338
- By:
- Publication type:
- Article
DFT-Based Quantum Mechanical and Molecular Docking Investigation of Synthesized Flavokawain B and Its Derivatives.
- Published in:
- Journal of the Chemical Society of Pakistan, 2025, v. 47, n. 1, p. 19
- By:
- Publication type:
- Article
Post‐marketing surveillance data for avelumab + axitinib treatment in patients with advanced renal cell carcinoma in Japan: Subgroup analyses by pathological classification.
- Published in:
- International Journal of Urology, 2025, v. 32, n. 3, p. 293, doi. 10.1111/iju.15646
- By:
- Publication type:
- Article
Current status of endoscopic ultrasound‐guided antitumor treatment for pancreatic cancer.
- Published in:
- Digestive Endoscopy, 2025, v. 37, n. 1, p. 18, doi. 10.1111/den.14815
- By:
- Publication type:
- Article
Construction of oral squamous cell carcinoma organoids in vitro 3D‐culture for drug screening.
- Published in:
- Oral Diseases, 2025, v. 31, n. 1, p. 99, doi. 10.1111/odi.15044
- By:
- Publication type:
- Article
Assessment of pain prevalence in cancer patients undergoing anticancer treatments and in cancer survivors after completion of anticancer treatments: A French nationwide cross‐sectional study.
- Published in:
- International Journal of Cancer, 2025, v. 156, n. 10, p. 1873, doi. 10.1002/ijc.35280
- By:
- Publication type:
- Article
Anticancer (cytotoxic, anticlonogenic, antimetastatic, immunomodulatory actions) properties of 3,5‐dibromosalicylaldehyde against glioblastoma cells and DFT analyses (FT‐IR, Raman, NMR, UV) as well as a molecular docking study.
- Published in:
- Biology of the Cell (Wiley-Blackwell), 2025, v. 117, n. 2, p. 1, doi. 10.1111/boc.202400138
- By:
- Publication type:
- Article
A phase 2 basket study of talabostat, a small‐molecule inhibitor of dipeptidyl peptidases, administered in combination with pembrolizumab in patients with advanced solid cancers.
- Published in:
- Cancer (0008543X), 2025, v. 131, n. 3, p. 1, doi. 10.1002/cncr.35728
- By:
- Publication type:
- Article
Impact of Acid‐Reducing Agents on Sotorasib Pharmacokinetics and Potential Mitigation of the Impact by Coadministration With an Acidic Beverage.
- Published in:
- Clinical Pharmacology in Drug Development, 2025, v. 14, n. 2, p. 167, doi. 10.1002/cpdd.1489
- By:
- Publication type:
- Article
Impact of oncologic diseases on outcome in patients with severe isolated tricuspid regurgitation.
- Published in:
- European Journal of Clinical Investigation, 2025, v. 55, n. 3, p. 1, doi. 10.1111/eci.14367
- By:
- Publication type:
- Article
Antitumor Effect of Apilactobacillus kosoi 10H by Inducing Immunostimulatory Macrophages.
- Published in:
- Cellular Microbiology, 2025, v. 2025, p. 1, doi. 10.1155/cmi/4115145
- By:
- Publication type:
- Article
Cutaneous Toxicities of MEK Inhibitor Use in Children: A Comparison of Binimetinib and Selumetinib.
- Published in:
- Pediatric Dermatology, 2025, v. 42, n. 1, p. 67, doi. 10.1111/pde.15792
- By:
- Publication type:
- Article
BF‐BOIN‐ET: A Backfill Bayesian Optimal Interval Design Using Efficacy and Toxicity Outcomes for Dose Optimization.
- Published in:
- Pharmaceutical Statistics, 2025, v. 24, n. 2, p. 1, doi. 10.1002/pst.2470
- By:
- Publication type:
- Article
A Model‐Based Trial Design With a Randomization Scheme Considering Pharmacokinetics Exposure for Dose Optimization in Oncology.
- Published in:
- Pharmaceutical Statistics, 2025, v. 24, n. 2, p. 1, doi. 10.1002/pst.2454
- By:
- Publication type:
- Article
Plasma‐Activated Hydrogel Synergies With Paclitaxel to Enhance the Anticancer Efficacy.
- Published in:
- Plasma Processes & Polymers, 2025, v. 22, n. 2, p. 1, doi. 10.1002/ppap.202400167
- By:
- Publication type:
- Article
Efficacy of metformin and verteporfin treatment alone or in combination in a murine head and neck cancer xenograft model.
- Published in:
- European Journal of Oral Sciences, 2025, v. 133, n. 1, p. 1, doi. 10.1111/eos.13034
- By:
- Publication type:
- Article
An In Vivo Study of LNS8801, a GPER Agonist, in a Spontaneous Melanoma‐Prone Mouse Model, TGS.
- Published in:
- Pigment Cell & Melanoma Research, 2025, v. 38, n. 1, p. 1, doi. 10.1111/pcmr.13197
- By:
- Publication type:
- Article
Unlocking the Chemical Diversity of Plant Catharanthus roseus: Nuclear Magnetic Resonance Spectroscopy Approach.
- Published in:
- Magnetic Resonance in Chemistry, 2025, v. 63, n. 3, p. 205, doi. 10.1002/mrc.5504
- By:
- Publication type:
- Article